What does clinical diagnostics — goodwill, impairment loss mean?

The amount by which the carrying value of goodwill assigned to the Clinical Diagnostics reporting unit exceeds its implied fair value. This charge indicates a decline in the expected future economic benefits of previously acquired diagnostic businesses.

Bio-Rad Laboratories, Inc. BIO.B Clinical Diagnostics — Goodwill, Impairment Loss

Discontinued — last reported Q4 '19

Similar metrics at other companies

DHRLife Sciences — Goodwill Impairment

$0—

RVTYDiagnostics — Goodwill

$1.86B-4.0%

RKTDirect to Consumer — Goodwill, Impairment Loss

$0—

LHDiagnostics — Goodwill

$5.61B—

CMIComponents — Goodwill, Impairment Loss

$0—

CAHPharmaceutical and Specialty Solutions — Goodwill, Impairment Loss

$184M—

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed March 2, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does clinical diagnostics — goodwill, impairment loss mean?: The amount by which the carrying value of goodwill assigned to the Clinical Diagnostics reporting unit exceeds its implied fair value. This charge indicates a decline in the expected future economic benefits of previously acquired diagnostic businesses.